SCHEMBL30632949

SCHEMBL30632949

Cc1cccc(/C=C/c2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NFE2L2 Q16236 4/20 0.70
▸ RELA Q04206 1/20 0.57
▸ NQO2 P16083 1/20 0.54
▸ PTGS1 P23219 2/20 0.51
▸ AHR P35869 1/20 0.51
▸ ALOX5 P09917 1/20 0.50
▸ PTGS2 P35354 1/20 0.50
▸ ERBB2 P04626 1/20 0.49
▸ CYP1A1 P04798 1/20 0.46
▸ CYP1B1 Q16678 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ FBP1 P09467 1/20 0.45
▸ CYP1A2 P05177 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22398154 1.00 NFE2L2 (0.70) NFE2L2RELANQO2PTGS1AHR
SCHEMBL22398153 1.00 NFE2L2 (0.70) NFE2L2RELANQO2PTGS1AHR
SCHEMBL13874966 0.91 NFE2L2 (0.84) NFE2L2RELAPTGS1ALOX5PTGS2
SCHEMBL1179749 0.84 RELA (0.74) NFE2L2RELAPTGS1ALOX5PTGS2
SCHEMBL29673932 0.84 RELA (0.74) NFE2L2RELAPTGS1ALOX5PTGS2
SCHEMBL1179750 0.84 RELA (0.74) NFE2L2RELAPTGS1ALOX5PTGS2
SCHEMBL17083047 0.82 NFE2L2 (1.00) NFE2L2FBP1
SCHEMBL13799367 0.81 NFE2L2 (0.67) NFE2L2RELANQO2PTGS1AHR
SCHEMBL13799369 0.81 NFE2L2 (0.67) NFE2L2RELANQO2PTGS1AHR
SCHEMBL13906334 0.81 NFE2L2 (0.67) NFE2L2RELANQO2PTGS1AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111886234-B Heterocyclic mitochondrial activity inhibitors and uses thereof 蒙特利尔大学 2023-12-15 — — CN disclosed
Send feedback